How We Innovate with Advanced Technologies
At AbbVie, cutting-edge technologies are helping scientists understand disease biology like never before.
We’ve doubled our investment in research the past decade, with new technologies supporting our quest to develop therapies and solutions.
We do whatever it takes to help develop medicines and solutions, knowing time is of the essence. Our ever-expanding scientific capabilities help us get there first. In fact, 80% of the therapies in our pipeline are considered first-in-class.
Our cutting-edge technologies are applied end-to-end across R&D, from early experimental work to understand disease pathways to in-house discovery of new assets to advancing late-stage programs.
We combine the best talent, diverse thinking, and state-of-the-art resources to advance new discoveries. See if a career with us is a good fit.
The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence. The Internet site that you have requested may not be optimized to your screen size. Do you wish to continue to this product-specific site?